|
| 37111592 | The Novel Artemisinin Dimer Isoniazide ELI-XXIII-98-2 Induces c-MYC Inhibition, DNA Damage, and Autophagy in Leukemia Cells. | | 2023 |
| 37570631 | Modes of Action of a Novel c-MYC Inhibiting 1,2,4-Oxadiazole Derivative in Leukemia and Breast Cancer Cells. | | 2023 |
| 37344563 | Cynaropicrin disrupts tubulin and c-Myc-related signaling and induces parthanatos-type cell death in multiple myeloma. | | 2023 |
| 37322258 | The cardiac glycoside ZINC253504760 induces parthanatos-type cell death and G2/M arrest via downregulation of MEK1/2 phosphorylation in leukemia cells. | | 2023 |
| 33884520 | Pyrrolizidine alkaloids cause cell cycle and DNA damage repair defects as analyzed by transcriptomics in cytochrome P450 3A4-overexpressing HepG2 clone 9 cells. | Cell Biology and Toxicology | 2022 |
| 35878807 | Novel artemisinin derivative FO8643 with anti-angiogenic activity inhibits growth and migration of cancer cells via VEGFR2 signaling. | European Journal of Pharmacology | 2022 |
| 36145342 | Modulation of Intestinal Corticotropin-Releasing Hormone Signaling by the Herbal Preparation STW 5-II: Possible Mechanisms for Irritable Bowel Syndrome Management. | Pharmaceuticals | 2022 |
| 35985681 | Disruption of Lipid Raft Microdomains, Regulation of CD38, TP53, and MYC Signaling, and Induction of Apoptosis by Lomitapide in Multiple Myeloma Cells. | Cancer Genomics and Proteomics | 2022 |
| 34582772 | Cytotoxicity of 4-hydroxy-N-(naphthalen-1-yl)-2-oxo-2H-chromene-3-carboxamide in multidrug-resistant cancer cells through activation of PERK/eIF2α/ATF4 pathway. | Biochemical Pharmacology | 2021 |
| 33485866 | DNA Promoter Methylation and ERG Regulate the Expression of CD24 in Prostate Cancer. | Am J Pathol | 2021 |
| 34111617 | Anti-inflammatory and tight junction protective activity of the herbal preparation STW 5-II on mouse intestinal organoids. | Phytomedicine | 2021 |
| 33669024 | <i>miR-449a</i> Repression Leads to Enhanced NOTCH Signaling in <i>TMPRSS2:ERG</i> Fusion Positive Prostate Cancer Cells. | Cancers (Basel) | 2021 |
| 34265280 | A novel moniliformin derivative as pan-inhibitor of histone deacetylases triggering apoptosis of leukemia cells. | Biochemical Pharmacology | 2021 |
| 34021777 | Selection of safe artemisinin derivatives using a machine learning-based cardiotoxicity platform and in vitro and in vivo validation. | Archives of Toxicology | 2021 |
| 33341310 | 2α-Hydroxyalantolactone from Pulicaria undulata: activity against multidrug-resistant tumor cells and modes of action. | Phytomedicine | 2021 |
| 34832908 | Repurposing of the ALK Inhibitor Crizotinib for Acute Leukemia and Multiple Myeloma Cells. | Pharmaceuticals | 2021 |
| 32957040 | Multiple modes of cell death in neuroendocrine tumors induced by artesunate. | Phytomedicine | 2020 |
| 32624584 | Quantitative genome-wide association study of six phenotypic subdomains identifies novel genome-wide significant variants in autism spectrum disorder. | Transl Psychiatry | 2020 |
| 32572023 | The role of rare compound heterozygous events in autism spectrum disorder. | Transl Psychiatry | 2020 |
| 30668345 | Adaptogens in chemobrain (Part III): Antitoxic effects of plant extracts towards cancer chemotherapy-induced toxicity - transcriptome-wide microarray analysis of neuroglia cells. | Phytomedicine | 2019 |
| 30901664 | Adaptogens in chemobrain (Part II): Effect of plant extracts on chemotherapy-induced cytotoxicity in neuroglia cells. | Phytomedicine | 2019 |
| 30668446 | Adaptogens in chemobrain (Part I): Plant extracts attenuate cancer chemotherapy-induced cognitive impairment - Transcriptome-wide microarray profiles of neuroglia cells. | Phytomedicine | 2019 |
| 29147782 | Common functional variants of the glutamatergic system in Autism spectrum disorder with high and low intellectual abilities. | J Neural Transm (Vienna) | 2018 |
| 29930110 | Analysis of shared heritability in common disorders of the brain. | Science | 2018 |
| 30200539 | Genome-Based Classification and Therapy of Prostate Cancer. | Diagnostics (Basel) | 2018 |
| 30515268 | Cytotoxicity of nimbolide towards multidrug-resistant tumor cells and hypersensitivity via cellular metabolic modulation. | Oncotarget | 2018 |
| 28445989 | TMPRSS2:ERG gene fusion variants induce TGF-β signaling and epithelial to mesenchymal transition in human prostate cancer cells. | Oncotarget | 2017 |
| 28912423 | The Chinese herbal formula Free and Easy Wanderer ameliorates oxidative stress through KEAP1-NRF2/HO-1 pathway. | Scientific Reports | 2017 |
| 26564229 | Anticancer activity of cryptotanshinone on acute lymphoblastic leukemia cells. | Archives of Toxicology | 2016 |
| 26926179 | Cryptotanshinone deregulates unfolded protein response and eukaryotic initiation factor signaling in acute lymphoblastic leukemia cells. | Phytomedicine | 2016 |
| 25224256 | Variants of the CNTNAP2 5' promoter as risk factors for autism spectrum disorders: a genetic and functional approach. | Molecular Psychiatry | 2015 |
| 26476154 | Molecular mechanisms of rosmarinic acid from Salvia miltiorrhiza in acute lymphoblastic leukemia cells. | Journal of Ethnopharmacology | 2015 |
| 26472107 | Inhibition of c-MYC with involvement of ERK/JNK/MAPK and AKT pathways as a novel mechanism for shikonin and its derivatives in killing leukemia cells. | Oncotarget | 2015 |
| 26290468 | A Novel Mutation in RPL10 (Ribosomal Protein L10) Causes X-Linked Intellectual Disability, Cerebellar Hypoplasia, and Spondylo-Epiphyseal Dysplasia. | Hum Mutat | 2015 |
| 25250334 | Novel RNA markers in prostate cancer: functional considerations and clinical translation. | Biomed Res Int | 2014 |
| 25363760 | Synaptic, transcriptional and chromatin genes disrupted in autism. | Nature | 2014 |
| 25392729 | The Autism Simplex Collection: an international, expertly phenotyped autism sample for genetic and phenotypic analyses. | Mol Autism | 2014 |
| 24442360 | Common variants in genes of the postsynaptic FMRP signalling pathway are risk factors for autism spectrum disorders. | Human Genetics | 2014 |
| 24768552 | Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. | Am J Hum Genet | 2014 |
| 24512814 | Protein signatures of oxidative stress response in a patient specific cell line model for autism. | Molecular Autism | 2014 |
| 23933821 | Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. | Nat Genet | 2013 |
| 21996756 | A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder. | Hum Genet | 2012 |
| 22843504 | Individual common variants exert weak effects on the risk for autism spectrum disorders. | Hum Mol Genet | 2012 |
| 22346768 | Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. | PLoS Genet | 2012 |
| 21656903 | No association between a common single nucleotide polymorphism, rs4141463, in the MACROD2 gene and autism spectrum disorder. | Am J Med Genet B Neuropsychiatr Genet | 2011 |
| 21442598 | [Genetic analyses for identifying molecular mechanisms in autism spectrum disorders]. | Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie | 2011 |
| 21472451 | [Genetics and animal modeling of autism spectrum disorders. New developments]. | Der Nervenarzt | 2011 |
| 21567917 | Mutation and expression analyses of the ribosomal protein gene RPL10 in an extended German sample of patients with autism spectrum disorder. | American Journal of Medical Genetics, Part A | 2011 |
| 20663923 | A genome-wide scan for common alleles affecting risk for autism. | Hum Mol Genet | 2010 |
| 20678249 | Polymorphisms in leucine-rich repeat genes are associated with autism spectrum disorder susceptibility in populations of European ancestry. | Mol Autism | 2010 |